Laryngopharyngeal Reflux Disease: Clinical Trials

4 trials for Laryngopharyngeal Reflux Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 not yet recruiting. 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1
Phase 41Not yet recruiting 1

Follow Laryngopharyngeal Reflux Disease: new trials by email Literature Review of Laryngopharyngeal Reflux Disease trials Research Report on Laryngopharyngeal Reflux Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease
Alginate, Magaldrate, Sucralfate - Laryngopharyngeal Reflux Disease
Phase 4Not yet recruitingUniversity of Mons8002026-05-012026-05-28
"The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences in the Voice?
Voice sample; Recording with microphone + Questionnaire - GERD Gastroesophageal Reflux Disease, Laryngopharyngeal Reflux Disease
UnknownInsel Gruppe AG, University Hospital Bern942024-04-102024-07-11
The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux Disease
Tegoprazan, Placebo - Laryngopharyngeal Reflux Disease
Phase 3CompletedPusan National University Hospital362019-10-012023-06-01
Trial of Proton Pump Inhibitor With Prokinetics or Placebo in Patients With Laryngopharyngeal Reflux Disease
Motilitone, Pantoprazole, Placebo - Laryngopharyngeal Reflux Disease
Phase 3UnknownSamsung Medical Center2002016-05-012016-06-01

Narrower conditions

Gastroesophageal Reflux (1)

Broader conditions

Deglutition Disorders (1)  ·  Digestive System Diseases (1)  ·  Esophageal Diseases (1)  ·  Esophageal Motility Disorders (1)  ·  Gastrointestinal Diseases (1)

Interventions

Alginates (1)  ·  Diet (1)  ·  Pantoprazole (1)  ·  Proton Pump Inhibitors (1)  ·  Sucralfate (1)  ·  Therapeutics (1)  ·  magaldrate (1)  ·  tegoprazan (1)

Sponsors

Insel Gruppe AG, University Hospital Bern (1)  ·  Pusan National University Hospital (1)  ·  Samsung Medical Center (1)  ·  University of Mons (1)

Countries

South Korea (2)  ·  Belgium (1)  ·  Switzerland (1)

Results publications

PMID 24782414, PMID 37834761

NIH funding

2023 (1)